Diet, exercise, brain games, even using your non-dominant hand can help prevent the onset of Alzheimer's disease.

The Phase Ia trial is designed to assess the safety and efficacy of the company’s drug designed to target chemicals thought ...

A predictive tool for determining the age at which individuals may develop mild cognitive impairment (MCI) or Alzheimer's ...

The finding has implications for all of us, write Harvard physician-researchers Christopher Worsham and Anupam Jena.

Groundbreaking research unveils potential link between cytomegalovirus and Alzheimer's disease, offering new hope for ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

It is believed most humans are ... First Successful Clinical Trial of VU319 Brings Alzheimer's Treatment One Step Closer Dec. 19, 2024 — Phase I clinical trial of a drug was successfully ...

Discover how a groundbreaking cognitive assessment tool is transforming early dementia detection with 99.9% accuracy and what this means for future treatment.

Cases of dementia in the U.S. are expected to steadily rise in the coming years, hitting 1 million annual cases by 2060.